AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 24491033
Drug: Paliperidone extended-release
RxNorm normalized name: Paliperidone Extended-Release Tablets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone extended-release (ER)
Trial: 22314630
Drug: Music intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Music intervention (20 minutes of standard postoperative care and music twice daily on postoperative days 2 through 4)
Trial: 8330544
Drug: Sedation with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedation with midazolam or diazepam suspension
Trial: 29672196
Drug: Synbiotic supplementation
RxNorm normalized name: Synotic
DrugBank: Fluocinolone acetonide (DB00591)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Synbiotic supplementation (twice a day for three months)
Trial: 10499601
Drug: rV-CEA vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rV-CEA vaccine
Trial: 28396999
Drug: Dutasteride 0.5
RxNorm normalized name: dutasteride 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 0.5 mg daily
Trial: 9179279
Drug: High-dose Ara-C
RxNorm normalized name: cytarabine
DrugBank: Cytarabine (DB00987)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: High-dose Ara-C (HDAC) combined with high dose mitoxantrone
Trial: 9124549
Drug: Arginine vasopressin
RxNorm normalized name: 1-deamino-8-D-arginine vasopressin
DrugBank: Desmopressin (DB00035)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Arginine vasopressin (AVP) infusion
Trial: 9038524
Drug: No preparation
RxNorm normalized name: cranberry preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preparation
Trial: 15096395
Drug: Topiramate 100
RxNorm normalized name: topiramate 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topiramate 100 mg/d
Trial: 15727691
Drug: Low dosage
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dosage (60 mg/d) of diisopropylamine dichloroacetate
Trial: 2970853
Drug: Hydrochlorothiazide (HCTZ)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydrochlorothiazide (HCTZ) 60 mg/day
Trial: 24904785
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg metoprolol the night before surgery
Trial: 16849623
Drug: pegaptanib 0.3
RxNorm normalized name: PEGAPTANIB 0.3MG/0.09ML INTRAOCULAR SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pegaptanib 0.3 mg intravitreous injection every 6 weeks for 48 weeks
Trial: 22136978
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg monotherapy
Trial: 9649101
Drug: Traditional postoperative
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional postoperative oral feeding
Trial: 6383734
Drug: SCH 370
RxNorm normalized name: SCH 58500
DrugBank: SCH-58500 (DB17416)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SCH 370 cream
Trial: 6383740
Drug: Methylprednisolone 64
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone 64 mg every other day (qod)
Trial: 9033712
Drug: Ketoconazole cream
RxNorm normalized name: Ketoconazole
DrugBank: Ketoconazole (DB01026)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ketoconazole cream (2%) applied once daily
Trial: 21665462
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (FOLFIRI)
Trial: 29682796
Drug: JNJ‐39758979 300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: JNJ‐39758979 300 mg once daily for 12 weeks
Trial: 17615904
Drug: Zinc gluconate
RxNorm normalized name: Zinc Gluconate
DrugBank: Zinc gluconate (DB11248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Zinc gluconate (10 mg elemental zinc) added to multi-vitamin syrup containing vitamin A
Trial: 2496428
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg intravenous (IV) cocaine with 2.5 mg oral bromocriptine pretreatment
Trial: 2496428
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg intravenous (IV) cocaine without bromocriptine pretreatment
Trial: 28606235
Drug: Sequential-Lactobacillus group
RxNorm normalized name: Lactobacillus reuteri
DrugBank: Lactobacillus reuteri (DB14224)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential-Lactobacillus group
Trial: 16883627
Drug: Chunghyul-dan (CHD)
RxNorm normalized name: Dan shen suan b
DrugBank: Salvianolic acid B (DB19313)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chunghyul-dan (CHD) 600 mg three times a day for 8 weeks
Trial: 14612206
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 2 g/day plus Vitamin E 400 IU/day (Group B)
Trial: 14612206
Drug: Vitamin C
RxNorm normalized name: Vitamin C
DrugBank: Sodium ascorbate (DB14482)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin C 2 g/day plus Vitamin E 800 IU/day (Group C)
Trial: 2502441
Drug: Clomiphene citrate
RxNorm normalized name: Clomiphene Citrate
DrugBank: Clomifene (DB00882)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate (CC)/hMG regimen
Trial: 17079573
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy of erythropoietin, iron, folate, and vitamin B12
Trial: 8742095
Drug: Bicalutamide in
RxNorm normalized name: Product containing bicalutamide in oral dose form (medicinal product form)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bicalutamide in combination with LHRH analogs
Trial: 27490922
Drug: ω-3 Fatty
RxNorm normalized name: ω-3 fatty acids
DrugBank: Omega-3 fatty acids (DB11133)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ω-3 Fatty Acid Ethyl Esters (4 g/d)
Trial: 3805752
Drug: Leukotriene D4
RxNorm normalized name: Leukotriene D4
DrugBank: Leukotriene D4 (DB11858)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Leukotriene D4 (LTD4) at doses of 3.1‐200 pmol
Trial: 2524387
Drug: Oral administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral administration of ipratropium bromide (20 mg)
Trial: 16434666
Drug: Creatine 8
RxNorm normalized name: Creatine 800 MG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Creatine 8 g/day for 16 weeks
Trial: 9625322
Drug: L-ornithine-L-aspartate
RxNorm normalized name: ornithine, (L)-isomer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-ornithine-L-aspartate
Trial: 30565017
Drug: Magnesium and
RxNorm normalized name: Calcium, Magnesium and Zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium and Vitamin E co-supplementation (250 mg/day magnesium plus 400 mg/day vitamin E)
Trial: 19340731
Drug: Postoperative administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative administration of omeprazole
Trial: 843096
Drug: Corn oil-in-water
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil-in-water emulsion (5, 10, 15, or 30 gm doses containing 250 mg of microsize griseofulvin)
Trial: 843096
Drug: Corn oil
RxNorm normalized name: Corn Oil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corn oil (10 gm dose of emulsion)
Trial: 28555204
Drug: Fixed-on-2 implants
RxNorm normalized name: trenbolone
DrugBank: Trenbolone acetate (DB14660)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-on-2 implants
Trial: 28555204
Drug: Fixed-on-4 implants
RxNorm normalized name: trenbolone
DrugBank: Trenbolone acetate (DB14660)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fixed-on-4 implants
Trial: 11287371
Drug: COP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: COP treatment
Trial: 8770026
Drug: Methylprednisolone (METH)
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylprednisolone (METH) intravenous infusion (125 mg/30 min) during weight maintenance diet
Trial: 23427865
Drug: Infusion rate
RxNorm normalized name: Duo Fusion
DrugBank: Magnesium hydroxide (DB09104)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Infusion rate of 0.1 mL/min
Trial: 8011000
Drug: Conventional fluorocarbon-containing
RxNorm normalized name: fluorocarbon blood substitutes
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional fluorocarbon-containing GTN spray (R)
Trial: 31816306
Drug: Outpatient ibuprofen
RxNorm normalized name: Ibuprofen
DrugBank: Ibuprofen (DB01050)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Outpatient ibuprofen plus acetaminophen (nonopioid, n=85)
Trial: 28824041
Drug: Canagliflozin 100
RxNorm normalized name: canagliflozin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Canagliflozin 100 mg/day + Teneligliptin 20 mg/day
Trial: 15057391
Drug: Etching with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etching with 36% phosphoric acid gel - Conditioner 36 (Dentsply) for 20 s, followed by water rinse for 15 s
Trial: 29743380
Drug: Discontinuation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Discontinuation of cilostazol
Trial: 27722854
Drug: Simvastatin 40
RxNorm normalized name: simvastatin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin 40 mg
Trial: 7863047
Drug: No Continuous
RxNorm normalized name: Lotion, Multi Ingredient Topical application Lotion [AVEENO CONTINUOUS RADIANCE MOISTURIZING LOTION]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No Continuous Ambulatory Oxygen Therapy (CAOT) - Group A
Trial: 25073921
Drug: Blood solution
RxNorm normalized name: dragon's blood extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blood solution
Trial: 11874410
Drug: Physiological hydrocortisone
RxNorm normalized name: Hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Physiological hydrocortisone infusion (PHI)
Trial: 11715153
Drug: Polysaccharide pneumococcal
RxNorm normalized name: PNEUMOCOCCAL POLYSACCHARIDE SEROTYPE 8
DrugBank: Streptococcus pneumoniae type 8 capsular polysaccharide antigen (DB10326)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Polysaccharide pneumococcal vaccine
Trial: 12619262
Drug: Benzocaine patch
RxNorm normalized name: Benzocaine
DrugBank: Benzocaine (DB01086)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Benzocaine patch (12 mg)
Trial: 22815837
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g type 2 resistant starch
Trial: 20974547
Drug: Solution A
RxNorm normalized name: I.V. SOLUTION ADDITIVES
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution A (Solo‐care Aqua(®), Ciba‐Vision)
Trial: 20974547
Drug: Solution B
RxNorm normalized name: DONISLECEL-JUJN RINSE SOLUTION BAG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Solution B (Hidro Health(®), Disop)
Trial: 16133961
Drug: Rabeprazole 10
RxNorm normalized name: RABEprazole 10 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rabeprazole 10 mg daily
Trial: 11809180
Drug: Omeprazole with
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole with placebo antibiotics (placebo group) for 1 week, followed by diclofenac slow release 100 mg daily for 6 months
Trial: 11809180
Drug: Omeprazole triple
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole triple therapy (eradication group) for 1 week, followed by diclofenac slow release 100 mg daily for 6 months
Trial: 31770287
Drug: Propofol-based total
RxNorm normalized name: Propofol
DrugBank: Propofol (DB00818)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Propofol-based total intravenous anesthesia (TIVA group, n=25)
Trial: 27904000
Drug: Flaxseed oil
RxNorm normalized name: Flaxseed Oil
DrugBank: Linseed oil (DB11357)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flaxseed oil (6 g/d for 8 weeks)
Trial: 8474318
Drug: 23 g
RxNorm normalized name: PEG-23 GLYCERYL DISTEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 23 g parboiled white rice
Trial: 16189090
Drug: Ciprofloxacin IR
RxNorm normalized name: Ciprofloxacin
DrugBank: Ciprofloxacin (DB00537)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin IR 250 mg twice daily for 3 days
Trial: 26045549
Drug: Conventional GnRH
RxNorm normalized name: GnRH
DrugBank: Gonadorelin (DB00644)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conventional GnRH antagonist protocol (Cetrotide 0.25 mg sc from day 2 to day 8, then Gn therapy added)
Trial: 7575051
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg nicotine polacrilex
Trial: 23729801
Drug: Ofatumumab 3
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab 3 mg
Trial: 23729801
Drug: Ofatumumab 30
RxNorm normalized name: Ofatumumab
DrugBank: Ofatumumab (DB06650)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Ofatumumab 30 mg
Trial: 799560
Drug: Diuretic (Hydrochlorothiazide)
RxNorm normalized name: Hydrochlorothiazide
DrugBank: Hydrochlorothiazide (DB00999)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diuretic (Hydrochlorothiazide)
Trial: 10949727
Drug: Low molecular
RxNorm normalized name: Low molecular weight heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low molecular weight heparin therapy
Trial: 21825093
Drug: Jin Shin
RxNorm normalized name: Yu Jin
DrugBank: Turmeric (DB14276)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Jin Shin Jyutsu (JSJ) treatments, 10 weekly sessions
Trial: 8027856
Drug: Trace minerals
RxNorm normalized name: HERBAL TRACE MINERALS LIQUID,ORAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trace minerals only (15.0 mg zinc/d, 5.0 mg manganese/d, 2.5 mg copper/d)
Trial: 11310461
Drug: Intranasal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal midazolam (0.4 mg/kg)
Trial: 17130429
Drug: Immediate antiepileptic
RxNorm normalized name: ANTIEPILEPTICS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate antiepileptic drug treatment
Trial: 11790928
Drug: Traditional antiarrhythmic
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional antiarrhythmic drug therapy (ADT)
Trial: 2184556
Drug: 50 mg
RxNorm normalized name: talc 50 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 50 mg atenolol and 12.5 mg chlorthalidone (Tenoretic Mite)
Trial: 29034644
Drug: Eicosapentaenoic Acid
RxNorm normalized name: eicosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eicosapentaenoic Acid (EPA) 2 g/day for 8 weeks
Trial: 31868879
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy followed by radical hysterectomy
Trial: 21030369
Drug: Liquid captopril
RxNorm normalized name: Captopril
DrugBank: Captopril (DB01197)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liquid captopril formulations
Trial: 10165114
Drug: Jet spacer
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Jet spacer device with inhaled beclomethasone dipropionate (0.5 mg twice daily)
Trial: 14667957
Drug: Eptifibatide +
RxNorm normalized name: Eptifibatide
DrugBank: Eptifibatide (DB00063)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eptifibatide + Unfractionated Heparin (UFH)
Trial: 18290855
Drug: Tadalafil 2.5
RxNorm normalized name: tadalafil 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tadalafil 2.5 mg
Trial: 10524634
Drug: UDCA 1200
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA 1200 mg/day
Trial: 10524634
Drug: UDCA 300
RxNorm normalized name: UDCA
DrugBank: Ursodeoxycholic acid (DB01586)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UDCA 300 mg/day
Trial: 21310372
Drug: Intracoronary adenosine
RxNorm normalized name: Adenosine
DrugBank: Adenosine phosphate (DB00131)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intracoronary adenosine (1 to 2 mg) administered 2 times during PCI
Trial: 22095631
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg every 6 months
Trial: 30602032
Drug: Denosumab 60
RxNorm normalized name: denosumab 60 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Denosumab 60 mg every 3 months
Trial: 12645832
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg 1.8-cineol t.i.d.
Trial: 2863090
Drug: Terfenadine tablets
RxNorm normalized name: terfenadine Oral Tablet
DrugBank: Terfenadine (DB00342)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Terfenadine tablets
Trial: 27135960
Drug: Intravenous Tranexamic
RxNorm normalized name: Tranexamic Acid
DrugBank: Tranexamic acid (DB00302)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous Tranexamic Acid (20 mg/kg)
Trial: 23218100
Drug: All atypical
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All atypical antipsychotics
Trial: 31676585
Drug: Magic therapy
RxNorm normalized name: Oxybenzone/Padimate O 3%-7% Topical application Stick [LIPMAGIC THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magic therapy intervention group (n = 34)
Trial: 31676585
Drug: Magic therapy
RxNorm normalized name: Oxybenzone/Padimate O 3%-7% Topical application Stick [LIPMAGIC THERAPY]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magic therapy intervention group (n = 47)
Trial: 10711866
Drug: Dexamethasone 1.0
RxNorm normalized name: TOBRAMYCIN 3.0 mg in 1 mL / DEXAMETHASONE 1.0 mg in 1 mL OPHTHALMIC SUSPENSION/ DROPS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexamethasone 1.0 mg/kg twice a day for 2 days
Trial: 7794289
Drug: Autohaler Inhalation
RxNorm normalized name: pirbuterol
DrugBank: Pirbuterol (DB01291)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Autohaler Inhalation Device (breath-activated MDI)
Trial: 3898835
Drug: Sucralfate administered
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate administered every six hours
Trial: 9506749
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose triamcinolone acetonide (L TAA, 800 microg/day)
Trial: 25432415
Drug: ER niacin
RxNorm normalized name: Leader Niacin 500mg Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ER niacin 2 g/day added to atorvastatin 10 mg
Trial: 6121605
Drug: nitrazepam 5
RxNorm normalized name: nitrazepam 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nitrazepam 5 mg
Trial: 30429050
Drug: Continuation of
RxNorm normalized name: varenicline
DrugBank: Varenicline (DB01273)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Continuation of heart failure medications (after initial 6 months)
Trial: 28923098
Drug: Baricitinib monotherapy
RxNorm normalized name: baricitinib
DrugBank: Baricitinib (DB11817)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Baricitinib monotherapy (4 mg once daily)
Trial: 21368386
Drug: Folic acid
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Folic acid 15 mg/d
Trial: 19841527
Drug: Routine folic
RxNorm normalized name: Folic Acid
DrugBank: Folic acid (DB00158)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Routine folic acid supplementation 10 mg/d
Trial: 15818702
Drug: 90 mg
RxNorm normalized name: papain 90 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 90 mg etoricoxib
Trial: 24811226
Drug: Nitroglycerin (NG)
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (NG) dermal patch
Trial: 14704645
Drug: Bio-Hep-B vaccine
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-Hep-B vaccine (2.5 microg)
Trial: 14704645
Drug: Bio-Hep-B vaccine
RxNorm normalized name: Hep B, unspecified formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bio-Hep-B vaccine (5 microg)
Trial: 11684212
Drug: Alternate-day rhDNase
RxNorm normalized name: Alternaria alternata
DrugBank: Alternaria alternata (DB10424)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day rhDNase (2.5 mg)
Trial: 7534320
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone and Conventional medical treatment
Trial: 25087308
Drug: Music therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Music therapy (listening to music during surgery)
Trial: 17230618
Drug: subcutaneous rhGH
RxNorm normalized name: rhGH
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: subcutaneous rhGH (0.15 IU/kg)
Trial: 29405507
Drug: Sham pill
RxNorm normalized name: BLACK BEAN ANTI HAIR LOSS SHAM POO SET KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham pill described as 'a well‐known tablet available without prescription'
Trial: 31846499
Drug: rESWT on
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rESWT on antagonist muscles (C)